Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !
AK Medical Holdings Zukünftiges Wachstum
Future Kriterienprüfungen 5/6
AK Medical Holdings wird ein jährliches Gewinn- und Umsatzwachstum von 26% bzw. 22.3% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 26% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 13.7% betragen.
Wichtige Informationen
26.0%
Wachstumsrate der Gewinne
26.0%
EPS-Wachstumsrate
| Medical Equipment Gewinnwachstum | 34.4% |
| Wachstumsrate der Einnahmen | 22.3% |
| Zukünftige Eigenkapitalrendite | 13.7% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 22 May 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Returns On Capital At AK Medical Holdings (HKG:1789) Paint A Concerning Picture
May 27
We Think AK Medical Holdings (HKG:1789) Can Stay On Top Of Its Debt
May 08Investors Appear Satisfied With AK Medical Holdings Limited's (HKG:1789) Prospects
Apr 21AK Medical Holdings Limited (HKG:1789) Analysts Are Reducing Their Forecasts For This Year
Apr 01AK Medical Holdings' (HKG:1789) Returns On Capital Not Reflecting Well On The Business
Jan 22Shareholders Should Be Pleased With AK Medical Holdings Limited's (HKG:1789) Price
Jan 04AK Medical Holdings (HKG:1789) Seems To Use Debt Rather Sparingly
Dec 12A Look At The Fair Value Of AK Medical Holdings Limited (HKG:1789)
Nov 09AK Medical Holdings (HKG:1789) Could Be Struggling To Allocate Capital
Sep 20AK Medical Holdings (HKG:1789) Could Easily Take On More Debt
Sep 03Investors Could Be Concerned With AK Medical Holdings' (HKG:1789) Returns On Capital
Jun 07Estimating The Fair Value Of AK Medical Holdings Limited (HKG:1789)
May 18Returns On Capital Signal Tricky Times Ahead For AK Medical Holdings (HKG:1789)
Feb 13Returns On Capital Signal Tricky Times Ahead For AK Medical Holdings (HKG:1789)
Nov 10Estimating The Fair Value Of AK Medical Holdings Limited (HKG:1789)
Sep 29Be Wary Of AK Medical Holdings (HKG:1789) And Its Returns On Capital
Aug 04Are Investors Undervaluing AK Medical Holdings Limited (HKG:1789) By 44%?
Jun 25There Are Reasons To Feel Uneasy About AK Medical Holdings' (HKG:1789) Returns On Capital
Apr 11Capital Allocation Trends At AK Medical Holdings (HKG:1789) Aren't Ideal
Oct 08Estimating The Intrinsic Value Of AK Medical Holdings Limited (HKG:1789)
Sep 20Analysts Are More Bearish On AK Medical Holdings Limited (HKG:1789) Than They Used To Be
Jul 27I Built A List Of Growing Companies And AK Medical Holdings (HKG:1789) Made The Cut
Jul 19AK Medical Holdings Limited (HKG:1789) Shares Could Be 39% Below Their Intrinsic Value Estimate
Jun 16The Returns On Capital At AK Medical Holdings (HKG:1789) Don't Inspire Confidence
Jun 01AK Medical Holdings Limited (HKG:1789) Analysts Are More Bearish Than They Used To Be
Apr 01Can You Imagine How Jubilant AK Medical Holdings' (HKG:1789) Shareholders Feel About Its 171% Share Price Gain?
Mar 19AK Medical Holdings Limited's (HKG:1789) Intrinsic Value Is Potentially 90% Above Its Share Price
Mar 01Do AK Medical Holdings's (HKG:1789) Earnings Warrant Your Attention?
Feb 14
What You Need To Know About AK Medical Holdings Limited's (HKG:1789) Investor Composition
Feb 01AK Medical Holdings Limited (HKG:1789) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Jan 20How Many AK Medical Holdings Limited (HKG:1789) Shares Did Insiders Buy, In The Last Year?
Jan 08Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 2,176 | 418 | 252 | 405 | 6 |
| 12/31/2025 | 1,784 | 339 | 128 | 325 | 7 |
| 12/31/2024 | 1,412 | 264 | 112 | 333 | 7 |
| 12/31/2023 | 1,094 | 182 | -162 | 34 | N/A |
| 9/30/2023 | 1,132 | 197 | -141 | 38 | N/A |
| 6/30/2023 | 1,170 | 211 | -121 | 42 | N/A |
| 3/31/2023 | 1,111 | 208 | 0 | 143 | N/A |
| 12/31/2022 | 1,052 | 205 | 121 | 243 | N/A |
| 9/30/2022 | 949 | 156 | 200 | 315 | N/A |
| 6/30/2022 | 845 | 107 | 278 | 387 | N/A |
| 3/31/2022 | 803 | 100 | 189 | 282 | N/A |
| 12/31/2021 | 761 | 93 | 100 | 177 | N/A |
| 9/30/2021 | 883 | 178 | 35 | 120 | N/A |
| 6/30/2021 | 1,004 | 263 | -30 | 64 | N/A |
| 3/31/2021 | 1,020 | 288 | 43 | 135 | N/A |
| 12/31/2020 | 1,035 | 314 | 115 | 205 | N/A |
| 9/30/2020 | 1,002 | 307 | 116 | 199 | N/A |
| 6/30/2020 | 968 | 300 | 116 | 194 | N/A |
| 3/31/2020 | 947 | 284 | 77 | 169 | N/A |
| 12/31/2019 | 927 | 267 | 38 | 145 | N/A |
| 9/30/2019 | 845 | 235 | 35 | 147 | N/A |
| 6/30/2019 | 763 | 203 | 33 | 150 | N/A |
| 3/31/2019 | 682 | 174 | 44 | 139 | N/A |
| 12/31/2018 | 601 | 145 | 54 | 128 | N/A |
| 9/30/2018 | 543 | 136 | 71 | 131 | N/A |
| 6/30/2018 | 485 | 127 | 87 | 135 | N/A |
| 3/31/2018 | 429 | 116 | 76 | 126 | N/A |
| 12/31/2017 | 373 | 105 | 65 | 117 | N/A |
| 9/30/2017 | 345 | 100 | N/A | 119 | N/A |
| 6/30/2017 | 318 | 94 | N/A | 120 | N/A |
| 3/31/2017 | 294 | 86 | N/A | 95 | N/A |
| 12/31/2016 | 271 | 77 | N/A | 70 | N/A |
| 12/31/2015 | 206 | 65 | N/A | 36 | N/A |
| 12/31/2014 | 148 | 52 | N/A | 51 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: 1789Das prognostizierte Gewinnwachstum (26% pro Jahr) liegt über der Sparquote (2.2%).
Ertrag vs. Markt: 1789Die Erträge des Unternehmens (26% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Hong Kong (12% pro Jahr).
Hohe Wachstumserträge: 1789Es wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: 1789Die Einnahmen des Unternehmens (22.3% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Hong Kong (7.9% pro Jahr).
Hohe Wachstumseinnahmen: 1789Die Einnahmen des Unternehmens (22.3% pro Jahr) werden voraussichtlich schneller wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: 1789Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (13.7 %).